398 related articles for article (PubMed ID: 25756434)
1. Are new oral anticoagulant dosing recommendations optimal for all patients?
Powell JR
JAMA; 2015 Mar; 313(10):1013-4. PubMed ID: 25756434
[No Abstract] [Full Text] [Related]
2. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
Koziński M; Obońska K; Kubica A; Navarese EP; Kubica J
Kardiol Pol; 2012; 70(10):1053-60. PubMed ID: 23080100
[No Abstract] [Full Text] [Related]
3. Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials.
Sardar P; Chatterjee S; Lavie CJ; Giri JS; Ghosh J; Mukherjee D; Lip GY
Int J Cardiol; 2015 Jan; 179():279-87. PubMed ID: 25464465
[TBL] [Abstract][Full Text] [Related]
4. [Evidence of novel oral anticoagulants (NOAC)].
Kitazono T
Rinsho Shinkeigaku; 2013; 53(11):992-3. PubMed ID: 24291856
[TBL] [Abstract][Full Text] [Related]
5. Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants.
Cuker A; Siegal DM; Crowther MA; Garcia DA
J Am Coll Cardiol; 2014 Sep; 64(11):1128-39. PubMed ID: 25212648
[TBL] [Abstract][Full Text] [Related]
6. Perioperative management of patients on new oral anticoagulants.
Lai A; Davidson N; Galloway SW; Thachil J
Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590
[TBL] [Abstract][Full Text] [Related]
7. Stroke prevention in atrial fibrillation: established oral anticoagulants versus novel anticoagulants-translating clinical trial data into practice.
Ezekowitz MD; Spahr J; Ghosh P; Corelli K
J Interv Card Electrophysiol; 2014 Sep; 40(3):261-8. PubMed ID: 24880227
[TBL] [Abstract][Full Text] [Related]
8. Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism.
Fontana P; Goldhaber SZ; Bounameaux H
Eur Heart J; 2014 Jul; 35(28):1836-43. PubMed ID: 24510637
[TBL] [Abstract][Full Text] [Related]
9. New oral anticoagulant agents - general features and outcomes in subsets of patients.
Schulman S
Thromb Haemost; 2014 Apr; 111(4):575-82. PubMed ID: 24452881
[TBL] [Abstract][Full Text] [Related]
10. Non-vitamin K antagonist oral anticoagulants (NOACs): a view from the laboratory.
Blann AD
Br J Biomed Sci; 2014; 71(4):158-67. PubMed ID: 25562993
[TBL] [Abstract][Full Text] [Related]
11. Newer oral anticoagulant agents: a new era in medicine.
Goel R; Srivathsan K
Curr Cardiol Rev; 2012 May; 8(2):158-65. PubMed ID: 22708914
[TBL] [Abstract][Full Text] [Related]
12. Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy.
Spyropoulos AC; Douketis JD; Gerotziafas G; Kaatz S; Ortel TL; Schulman S;
J Thromb Haemost; 2012 Apr; 10(4):692-4. PubMed ID: 22934291
[No Abstract] [Full Text] [Related]
13. Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons.
Verdecchia P; Angeli F; Lip GY; Reboldi G
PLoS One; 2014; 9(6):e100478. PubMed ID: 24955573
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with novel oral anticoagulants for thromboprophylaxis after elective hip and knee arthroplasty.
Messerschmidt C; Friedman RJ
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):771-8. PubMed ID: 25767271
[TBL] [Abstract][Full Text] [Related]
15. [New direct oral anticoagulants and venous thromboprophylaxis].
Degirmenci SE; Steib A
Rev Prat; 2013 Sep; 63(7):976-9. PubMed ID: 24167901
[TBL] [Abstract][Full Text] [Related]
16. Direct oral anticoagulants in the management of venous thromboembolism--evidence from major clinical trials.
Holy EW; Beer JH
Semin Hematol; 2014 Apr; 51(2):131-8. PubMed ID: 24861797
[TBL] [Abstract][Full Text] [Related]
17. New oral anticoagulants and oculoplastic surgery.
Ing E; Douketis J
Can J Ophthalmol; 2014 Apr; 49(2):123-7. PubMed ID: 24767215
[TBL] [Abstract][Full Text] [Related]
18. What's the "go to" anticoagulant for stroke prevention in atrial fibrillation?
Goldhaber SZ
Thromb Haemost; 2012 Mar; 107(3):397-8. PubMed ID: 22318737
[No Abstract] [Full Text] [Related]
19. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
Lane DA; Wood K
Circulation; 2015 Apr; 131(16):e412-5. PubMed ID: 25901074
[No Abstract] [Full Text] [Related]
20. Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants.
Schmitz EM; Boonen K; van den Heuvel DJ; van Dongen JL; Schellings MW; Emmen JM; van der Graaf F; Brunsveld L; van de Kerkhof D
J Thromb Haemost; 2014 Oct; 12(10):1636-46. PubMed ID: 25142183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
